CytomX Therapeutics

CytomX Therapeutics

CytomX Therapeutics

CytomX Therapeutics is an early-stage biotechnology company developing Probodies, proteolytically-activated antibodies.
Founded
2008
Raised
$33.5M
Follow us
Alexa global traffic share
Latest funding Show all
$20,000,000
Venture capital (Series C) - 2015
Canaan Partners Roche Venture Fund Third Rock Ventures +1
$11,000,000
Venture capital (Series B) - 2012
Canaan Partners Third Rock Ventures
Team Size
10+
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when CytomX Therapeutics makes some noise.